Acurx Pharmaceuticals, Inc.
ACXP
$4.08
$0.225.70%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -4.67% | -47.94% | -50.41% | -18.29% | -30.45% |
Total Receivables | -21.33% | -- | -60.45% | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -68.23% | -14.00% | -5.39% | 16.18% | 87.32% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -6.42% | -47.24% | -49.96% | -16.42% | -28.75% |
|
|||||
Total Current Assets | -6.42% | -47.24% | -49.96% | -16.42% | -28.75% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -6.42% | -47.24% | -49.96% | -16.42% | -28.75% |
|
|||||
Total Accounts Payable | -56.44% | -63.04% | 26.32% | 63.25% | -21.71% |
Total Accrued Expenses | -17.68% | -19.68% | 6.57% | 2.74% | 4.53% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -17.81% | -19.81% | 6.59% | 2.96% | 4.42% |
|
|||||
Total Current Liabilities | -17.81% | -19.81% | 6.59% | 2.96% | 4.42% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -17.81% | -19.81% | 6.59% | 2.96% | 4.42% |
|
|||||
Common Stock & APIC | 15.56% | 12.87% | 17.36% | 29.14% | 27.22% |
Retained Earnings | -16.20% | -20.62% | -26.50% | -34.17% | -37.19% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 4.05% | -61.47% | -86.82% | -32.29% | -44.86% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 4.05% | -61.47% | -86.82% | -32.29% | -44.86% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 4.05% | -61.47% | -86.82% | -32.29% | -44.86% |
|